Designing Ruthenium Anticancer Drugs: What Have We Learnt from the Key Drug Candidates?
Coverdale, J.P.C.; Laroiya-McCarron, T.; Romero-Canelón, I. Designing Ruthenium Anticancer Drugs: What Have We Learnt from the Key Drug Candidates? Inorganics 2019, 7, 31. https://0-doi-org.brum.beds.ac.uk/10.3390/inorganics7030031
Coverdale JPC, Laroiya-McCarron T, Romero-Canelón I. Designing Ruthenium Anticancer Drugs: What Have We Learnt from the Key Drug Candidates? Inorganics. 2019; 7(3):31. https://0-doi-org.brum.beds.ac.uk/10.3390/inorganics7030031
Chicago/Turabian StyleCoverdale, James P.C., Thaisa Laroiya-McCarron, and Isolda Romero-Canelón. 2019. "Designing Ruthenium Anticancer Drugs: What Have We Learnt from the Key Drug Candidates?" Inorganics 7, no. 3: 31. https://0-doi-org.brum.beds.ac.uk/10.3390/inorganics7030031